Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Yi-Han Hsiao, Ching-Min Tseng, Chau-Chyun Sheu, Hsin-Yi Wang, Hsin-Kuo Ko, Kang-Cheng Su, Chi-Wei Tao, Ming-Ju Tsai & Yen-Fu Chen. (2022) Shared Decision-Making Facilitates Inhaler Choice in Patients with Newly-Diagnosed Chronic Obstructive Pulmonary Disease: A Multicenter Prospective Study. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2067-2078.
Read now
Read now
Anne Tschacher, Cordula Cadus, Sebastian Schildge, Jens Peter Diedrich, Prashant N. Chhajed, Anne B. Leuppi-Taegtmeyer & Jörg Daniel Leuppi. (2021) Switching COPD patients from the disposable to the new reusable Respimat soft mist inhaler: a real-world study from Switzerland. Current Medical Research and Opinion 37:11, pages 2019-2033.
Read now
Read now
Ileen Gilbert, Keiko Wada, Chakkarin Burudpakdee, Chirag Ghai & Laren Tan. (2020) The Impact of a Forced Non-Medical Switch of Inhaled Respiratory Medication Among Patients with Asthma or Chronic Obstructive Pulmonary Disease: A Patient Survey on Experience with Switch, Therapy Satisfaction, and Disease Control. Patient Preference and Adherence 14, pages 1463-1475.
Read now
Read now
Kaho Akimoto, Kuniaki Hirai, Tomohiro Matsunaga, Keisuke Kaneko, Hatsuko Mikuni, Tomoko Kawahara, Tomoki Uno, Akiko Fujiwara, Yoshito Miyata, Shin Ohta, Tetsuya Homma, Hideki Inoue, Fumihiro Yamaguchi, Sojiro Kusumoto, Shintaro Suzuki, Akihiko Tanaka & Hironori Sagara. (2020) The Relationship Between the “Adherence Starts with Knowledge-20” Questionnaire and Clinical Factors in Patients with COPD: A Multi-Center, Cross-Sectional Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 3201-3211.
Read now
Read now
Omar S Usmani. (2019) Choosing the right inhaler for your asthma or COPD patient. Therapeutics and Clinical Risk Management 15, pages 461-472.
Read now
Read now
Marija Vukoja, Ivan Kopitovic, Zorica Lazic, Branislava Milenkovic, Ivana Stankovic, Biljana Zvezdin, Aleksandra Dudvarski Ilic, Ivan Cekerevac, Miodrag Vukcevic, Vladimir Zugic & Sanja Hromis. (2019) Diagnosis and management of chronic obstructive pulmonary disease in Serbia: an expert group position statement. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1993-2002.
Read now
Read now
Christos Chouaid, Nicola Germain, Gérard De Pouvourville, Samuel Aballéa, Daria Korchagina, Michael Baldwin, Katell Le Lay, Laura Luciani, Mondher Toumi & Philippe Devillier. (2019) Patient preference for chronic obstructive pulmonary disease (COPD) treatment inhalers: a discrete choice experiment in France. Current Medical Research and Opinion 35:5, pages 785-792.
Read now
Read now
David Price, Dorothy L Keininger, Boomi Viswanad, Matthias Gasser, Susann Walda & Florian S Gutzwiller. (2018) Factors associated with appropriate inhaler use in patients with COPD – lessons from the REAL survey. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 695-702.
Read now
Read now
Eleftherios Zervas, Konstantinos Samitas & Mina Gaga. (2016) Assessment of satisfaction with different dry powder inhalation devices in Greek patients with COPD and asthma: the ANASA study. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 1845-1855.
Read now
Read now
Articles from other publishers (20)
Natalia V. Trushenko, Anna A. Stoliarevich, Boris G. Andriukov, Galiya S. Nuralieva, Natalya A. Tsareva, Baina B. Lavginova & Sergey N. Avdeev. (2023) Assessment of inhalation technique in patients with bronchial asthma and chronic obstructive pulmonary disease. Terapevticheskii arkhiv 95:3, pages 210-216.
Crossref
Crossref
Paschalis Steiropoulos, Stavros Tryfon, Christos Kyriakopoulos, Konstantinos Bartziokas & Konstantinos Kostikas. (2021) Evaluation of the Clinical Effectiveness of the Salmeterol/Fluticasone Fixed-Dose Combination Delivered via the Elpenhaler® Device in Greek Patients with Chronic Obstructive Pulmonary Disease and Comorbidities: The AEOLOS Study. Journal of Personalized Medicine 11:11, pages 1159.
Crossref
Crossref
Adrian Gillissen, Andrea Marseille, Dirk Skowasch, John Ritz, Muriel Mattiucci-Guehlke, Stefan Pabst, Timm Greulich & Rembert Koczulla. (2021) Health and functional status of tiotropium/olodaterol-treated patients with COPD: results from the AERIAL® non-interventional study. ERJ Open Research 7:3, pages 00004-2021.
Crossref
Crossref
Ileen Gilbert, Aanam Aslam Mahmood, Katie Devane & Laren Tan. (2021) Association of Nonmedical Switches in Inhaled Respiratory Medications with Disruptions in Care: A Retrospective Prescription Claims Database Analysis. Pulmonary Therapy 7:1, pages 189-201.
Crossref
Crossref
Michael Dreher, David Price, Asparuh Gardev, Pascale Peeters, Satish Arora, Simone van der Sar – van der Brugge, Richard Dekhuijzen & Omar S Usmani. (2021)
Patient perceptions of the re-usable Respimat
®
Soft Mist™ inhaler in current users and those switching to the device: A real-world, non-interventional COPD study
. Chronic Respiratory Disease 18, pages 147997312098622.
Crossref
Crossref
Christian Taube, Valentina Bayer, Christoph Michael Zehendner & Arschang Valipour. (2020) Assessment of Patient Experiences with Respimat® in Everyday Clinical Practice. Pulmonary Therapy 6:2, pages 371-380.
Crossref
Crossref
Theodoros Karampitsakos, Georgios Hillas, Eleftherios Zervas, Petros Bakakos, Grigorios Stratakos, Katerina Dimakou, Efrosyni Manali, Demosthenes Bouros, Spyridon Papiris, Argyrios Tzouvelekis, Vasilios Adamidis, Helen Adamou, Xenophon Agelidis, Konstantinos Albantakis, Aikaterini Anaplioti, Christos Babalis, George Balasoulis, Konstantinos Christou, Christina Filippidou, Emmanuel Fothiantakis, Anna Gavriilidou, Hypakoe Goulia, Konstantina Houliara, Elias Kainis, Paschalis Kakavelas, Dionysia Kalampoka, George Kalfountzos, Savvas Kammenidis, Konstantinos Karkanis, Eugenia Karyanou, Maria Katertzi, Antonios Kopanakis, Georgia Kotantoula, Adamantia Liapikou, Efrosyni Manali, Nikolaos Manolakoglou, Konstantinos Marosis, Demetrios Michailidou, Peter Oikonomides, Anastasios Palamidas, Athanasios Papandreou, Athanasia Pataka, Athanasios Pitenis, Konstantinos Porpodis, Andreas Stratis, Chrysavgi Terovitou, Evangelia Trikrika, Pashalia Tsiaga, Theodora Tsiounta, Athina Vlachou & Dimitrios Zois. (2020) Prospective evAluatIon foR inhalation devices in Greek patients with COPD and asthma: The PAIR study. Pulmonary Pharmacology & Therapeutics 60, pages 101882.
Crossref
Crossref
Maryam Navaie, Carole Dembek, Soojin Cho-Reyes, Karen Yeh & Bartolome R. Celli. (2020) Inhaler device feature preferences among patients with obstructive lung diseases. Medicine 99:25, pages e20718.
Crossref
Crossref
Takashi Iwanaga, Yuji Tohda, Shuhei Nakamura & Yasunori Suga. (2019) The Respimat® Soft Mist Inhaler: Implications of Drug Delivery Characteristics for Patients. Clinical Drug Investigation 39:11, pages 1021-1030.
Crossref
Crossref
Anthony D’Urzo, Kenneth R. Chapman, James F. Donohue, Peter Kardos, M. Reza Maleki-Yazdi & David Price. (2019) Inhaler Devices for Delivery of LABA/LAMA Fixed-Dose Combinations in Patients with COPD. Pulmonary Therapy 5:1, pages 23-41.
Crossref
Crossref
Hannah A. Blair. (2019) Tiotropium/Olodaterol: A Review in COPD. Drugs 79:9, pages 997-1008.
Crossref
Crossref
Anna-Maria Ciciliani, Peter Langguth & Herbert Wachtel. (2019) Handling forces for the use of different inhaler devices. International Journal of Pharmaceutics 560, pages 315-321.
Crossref
Crossref
Maria Vera Cruz de Oliveira, Emilio Pizzichini, Claudia Henrique da Costa, Carlos Cezar Fritscher, Elcio Oliveira Vianna, Paulo José Zimermann Teixeira, Roberto Stirbulov, Marcelo Fouad Rabahi & Nadine Cordeiro de Pinho. (2018) Evaluation of the preference, satisfaction and correct use of Breezhaler® and Respimat® inhalers in patients with chronic obstructive pulmonary disease – INHALATOR study. Respiratory Medicine 144, pages 61-67.
Crossref
Crossref
Jane Scullion. (2018) The Nurse Practitioners’ Perspective on Inhaler Education in Asthma and Chronic Obstructive Pulmonary Disease. Canadian Respiratory Journal 2018, pages 1-9.
Crossref
Crossref
Marc Miravitlles, Juan José Soler-Cataluña, Bernardino Alcázar, José Luis Viejo & Francisco García-Río. (2018) Factors affecting the selection of an inhaler device for COPD and the ideal device for different patient profiles. Results of EPOCA Delphi consensus. Pulmonary Pharmacology & Therapeutics 48, pages 97-103.
Crossref
Crossref
Sinthia Zrinka Bosnic-Anticevich. (2018) Continued Innovation in Respiratory Care: The Importance of Inhaler Devices. Tuberculosis and Respiratory Diseases 81:2, pages 91.
Crossref
Crossref
David M. Halpin, Alan G. Kaplan & Richard K. Russell. (2017) Why choose tiotropium for my patient? A comprehensive review of actions and outcomes versus other bronchodilators. Respiratory Medicine 128, pages 28-41.
Crossref
Crossref
Herbert Wachtel, Sabine Kattenbeck, Stephen Dunne & Bernd Disse. (2017) The Respimat® Development Story: Patient-Centered Innovation. Pulmonary Therapy 3:1, pages 19-30.
Crossref
Crossref
Mario Cazzola, Josuel Ora, Ermanno Puxeddu & Paola Rogliani. (2017) Indacaterol/Glycopyrronium Combination for COPD. Pulmonary Therapy 3:1, pages 45-57.
Crossref
Crossref
Paola Rogliani, Luigino Calzetta, Angelo Coppola, Francesco Cavalli, Josuel Ora, Ermanno Puxeddu, Maria Gabriella Matera & Mario Cazzola. (2017) Optimizing drug delivery in COPD: The role of inhaler devices. Respiratory Medicine 124, pages 6-14.
Crossref
Crossref